News

This is some blog description about this site
Featured

Dr. Laura Klitten joins Clinical Microbiomics to further strengthen the company's marketing and business development activities

Clinical Microbiomics is pleased to announce that Dr. Laura Klitten has joined the team as a Sales & Business Development Director. Laura brings more than 10 years of commercial experience to the company and holds a BSc in Biology, a MSc in Human Biology and a PhD in Medical Genetics from the University of Copenhagen. Before staring her academic career, she was trained and worked in the dairy industry for five years working with fermentation on a large-scale industry level. In 2012 she acquired her PhD and joined the Danish life science company Exiqon (now part of OIAGEN) in the sales and marketing team. Quickly she was appointed Global Product Manager for Exiqon’s service facility where she played a leading role in the business development and commercial growth of Exiqon Services delivering high-quality transcriptome and microRNA profiling service for research customers worldwide. 

“I am proud that Clinical Microbiomics has selected me to join their team. I am thrilled about being part of an organization that provides customers with top-tier level clinical and pre-clinical research services within the microbiome space. Personally, this role is a dream come true for me. With Clinical Microbiomics I can fully use my commercial skills and experience to make sure we as a company focus even more on our clients where our end-to-end service makes it easy for them to conduct extremely high-quality clinical and pre-clinical  microbiome research. I look forward to being part of a team where we, in partnership with clients, develop, validate and run an impressive array of superior-level bioinformatics and advanced statistical analysis to accelerate their research in this young and inspiring research field. I am proud to join a team that is on the forefront in bioinformatically difficult areas”, says Laura Klitten.      

About Clinical Microbiomics
Clinical Microbiomics is a leading microbiome metagenomics service provider. We develop novel bioinformatics tools and integrative systems biology methods for state-of-the-art microbiome analysis. Our proprietary metagenomics platform provides our partners with leading capabilities for microbiome discovery and clinical research.

...
Continue reading
113 Hits

Sales and Business Development Manager / Director at Clinical Microbiomics

Clinical-Microbiomics is seeking a talented and highly motivated Sales and Business Development Manager / Director to develop and maintain sales and business relationships in one of the fastest growing research areas on the globe – the human microbiome.

...
Continue reading
413 Hits
Featured

Clinical Microbiomics receives ISO/IEC 17025:2005 accreditation

...
Continue reading
599 Hits
Featured

Dr. Jens Roat Kultima (previously JHMI) joins Clinical Microbiomics to further strengthen the company’s leading position in microbiome metagenomics

...
Continue reading
1092 Hits

Clinical Microbiomics is seeking a highly talented laboratory technician

At Clinical Microbiomics we are looking for a talented and dedicated laboratory technician to join our rapidly growing team in Copenhagen.

Clinical Microbiomics is a leading provider of advanced microbiome analyses for global pharma, nutrition and academic clients. The laboratory technician position is an excellent opportunity for an individual interested in the emerging field of the microbiome and its relation to a variety of complex diseases, such as diabetes, cancer and IBD.

...
Continue reading
1643 Hits

Clinical Microbiomics Strengthens Capabilities Within Immunotherapy Target Discovery and Personalized Medicine

Clinical Microbiomics is pleased to announce that Dr. Aron Charles Eklund has joined the team as Director of Bioinformatics. Aron has 16 years experience in bioinformatics and was most recently an Associate Professor at the Technical University of Denmark, where his research focused on development and application of cutting-edge genomics and computational methods for cancer diagnosis, personalized treatment, and target discovery for immunotherapy. His works, including 43 scientific articles and 4 patent applications, have been cited over 10,000 times. His experience managing and executing computational genomics projects will be a strong asset for the company and our clients.

...
Continue reading
1108 Hits

Clinical-Microbiomics Further Strengthens Bioinformatics Team

Clinical-Microbiomics is pleased to announce a further strengthening of our bioinformatics team. Albert Palleja Caro is a valuable new signing with significant experience in shotgun metagenomics analyses of interventional studies targeting directly or indirectly the gut microbiota of human donors. He has been the main driver of studies characterizing the effects of gastric bypass, weight loss and antibiotics on the gut microbiota. Besides this he has been involved in studies looking to find microbial markers for colorectal cancer and childhood obesity in humans, and multiple sclerosis in mice.

Albert holds a PhD in genome structure of bacterial genomes from the University of Tarragona (Catalunya, Spain). Previously to joining Clinical-Microbiomics, Albert has been a postdoc at the NNF Center for Protein Research studying protein networks related to human diseases under Lars Juhl Jensen and Søren Brunak, and at the NNF Center for Basic Metabolic Research working within the microbiome field under Manimozhiyan Arumugam.

...
Continue reading
1405 Hits

Clinical-Microbiomics Expands Science Team

It’s our great pleasure to welcome Jacob Bak Holm as new member of our team. Jacob is a valuable new signing that will further strengthen our team with state-of-the-art expertise within the field of microbiota research. Jacob holds a PhD in gut microbiota from University of Copenhagen and was prior to joining Clinical-Microbiomics, working as a postdoc in Laboratory of Genomics and Molecular Biomedicine at University of Copenhagen under professor Karsten Kristiansen. Here, Jacob has been in charge of multiple highly controlled studies focused on dietary or pathogenic modulations of the gut microbiota and its functional consequences for the host by the use of human and/or animal models. Jacob has excellent skills in both leading, performing and analyzing the scientific studies and is supported by a solution-focused mentality and a strong intellectual biological/biomedical background. Jacob will take the role as Director of Scientific Operations and will be leading projects while adding new expertise and knowledge to our team. 

About Clinical Microbiomics A/S
Clinical-Microbiomics is a world-leading contract research organization specialized in microbiome metagenomics. Through state-of-the-art sequencing and development of tailor-made bioinformatics tools, we assist partners across pharmaceutical, food, nutritional and agricultural industries to extract key biological insights from microbiome research. For more information, visit www.clinical-microbiomics.com. 

...
Continue reading
1381 Hits

Chronic Sleep Disruption Alters Gut Microbiome

New research finds fragmented sleep has significant effects on the gut microbiome, and for subsequent fat storage.

...
Continue reading
1480 Hits

Diet Crucial for Cognitive Effects of the Gut Microbiota

Starch rich diets can influence the gut microbiota and subsequently behavior, researchers are reporting. 

 

...
Continue reading
2930 Hits

How the Gut Prevents Parkinson’s Disease

New research shows cells in your gut induce immune responses through chemical signals, preserving neurons which are thought to perish during manifestation of Parkinson’s Disease.

 

...
Continue reading
1151 Hits

Microbiome Gene Expression Study Reveals How Gut Bacteria Interact

The largest microbiome gene expression study to date, conducted by the members of the Clinical-Microbiomics team, reveals how gut bacteria behave when they interact with each other.  

 

...
Continue reading
2567 Hits

Gut Microbiome Influences the Heart Disease Risks of Diet

Caution against eating eggs and meat by some scientists has arisen due to their production of trimethylamine N-oxide (TMAO), a dietary compound associated with heart disease. Researchers are now revealing that the gut microbiome has an influential role in this interplay.  

 

...
Continue reading
1988 Hits

Gene & Microbiome Interplay Influences IBD

According to a new study by a team of Caltech researchers, inflammatory bowel disease (IBD) may partly be caused by genetic variants that prevent particular gut microbes from executing their functional roles. 

 

...
Continue reading
952 Hits

Gut Microbes May Mediate Effects of Metformin

Metformin, a typical diabetes treatment regime, appears to be influenced by gut microbial communities, according to the latest findings by a team of researchers(1)

...
Continue reading
1243 Hits

Gubra and Clinical-Microbiomics Announces Pre-clinical Microbiome Partnership

Two renowned research companies – one focused on preclinical research and discovery, the other on tailored microbiomic analysis – team up in order to help uncover the microbiomic components of diabetes, obesity and NAFLD/NASH

Hørsholm, August 29, 2016 – Gubra ApS and Clinical-Microbiomics A/S announced today a strategic partnership focusing on analyzing the role of the microbiome in conditions related to diabetes, obesity and NAFLD/NASH. The combined expertise and resources of these two world-leading research companies will enable a fast and customer tailored pre-clinical assessment of the impact of drugs and diet on the gut microbiome.

...
Continue reading
1772 Hits

New study published in Nature Microbiology gives first insights into the microbial community-wide transcriptional interactions

Clinical-Microbiomics is proud to announce the publication of the largest gene expression study of the human gut microbiome to date. 

The study was done by integrating metagenomics and metatranscriptomics data, describing the expression of over 700.000 genes from hundreds of bacterial species, and the results suggest that regulation of gene expression plays an important role in species adaptation to coexistence. The study was conducted at Technical University of Denmark and lead by our CSO, Henrik Bjørn Nielsen.

...
Continue reading
1773 Hits